These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24379612)

  • 1. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection.
    Lu T; Seto WK; Zhu RX; Lai CL; Yuen MF
    World J Gastroenterol; 2013 Dec; 19(47):8887-94. PubMed ID: 24379612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
    Lok AS
    J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
    Pár A
    Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.
    Liu CJ; Chu YT; Shau WY; Kuo RN; Chen PJ; Lai MS
    Gut; 2014 Mar; 63(3):506-14. PubMed ID: 23676440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
    Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
    Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus and hepatitis C virus dual infection.
    Caccamo G; Saffioti F; Raimondo G
    World J Gastroenterol; 2014 Oct; 20(40):14559-67. PubMed ID: 25356020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic viruses and hepatocellular carcinoma.
    Ben Ari Z; Weitzman E; Safran M
    Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hepatocellular carcinoma in Japan.
    Umemura T; Ichijo T; Yoshizawa K; Tanaka E; Kiyosawa K
    J Gastroenterol; 2009; 44 Suppl 19():102-7. PubMed ID: 19148802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
    Ueno Y; Sollano JD; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
    Michielsen P; Ho E; Francque S
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does antiviral therapy prevent hepatocellular carcinoma?
    Kwon H; Lok AS
    Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [History and presence of hepatitis B and C therapy].
    Husa P
    Vnitr Lek; 2017; 63(7-8):465-470. PubMed ID: 28933169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: paradigm of preventive oncology.
    O'Brien TR; Kirk G; Zhang M
    Cancer J; 2004; 10(2):67-73. PubMed ID: 15130266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.
    Stournaras E; Neokosmidis G; Stogiannou D; Protopapas A; Tziomalos K
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1277-1282. PubMed ID: 30179906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatitis C virus-related hepatocellular carcinoma.
    Heathcote EJ
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S294-302. PubMed ID: 15508097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.